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cluded from the review. The studies included were categorised based on criteria
such as type of study, statistical methods for the learning effect, mathematical
framework for the economic analysis, year of publication, country and
intervention. RESULTS: The database search produced 930 articles. Only 2% of the
studies obtained were included given the above criteria. Of the excluded studies,
70% were excluded as they were not economic evaluations and 23% were excluded
as they did not formally present the learning effect. The remaining 7% were ex-
cluded based on other reasons: duplicates, non-English, non-human. The majority
of the studies are published after 2000. Of the included studies, the majority pre-
sented a learning effect related to health care costs. Two percent of the included
studies referred to utilities. Only one study synthesised cost and utilities.
CONCLUSIONS: Although the learning effect can have a notable impact on the
effectiveness of health care interventions, the economic evaluation literature on
the subject is very limited.
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OBJECTIVES: The Mutuelle Générale des Fonctionnaires et Agents de l’État de Côte
d’Ivoire (MUGEFCI) is a health mutual providing coverage services for its enrolees
(medical consultations, lab tests, medication expenses). This organization aims at
improving its current drug reimbursement process because of budgetary con-
straints. This study, therefore, aims at evaluating the feasibility of developing a
new formulary for the MUGEFCI in Côte d’Ivoire, by implementing a formulary-
listing framework specifically designed for under researched settings. METHODS:
The application of this framework, based on Multi-criteria Decision Analysis
(MCDA), consisted in four steps. First of all, we identified and weighted relevant
formulary listing criteria with their levels of variation. Then, we determined a set of
priority diagnostic/treatments to be assessed. Furthermore, scores were assigned
to these treatments according to their performance on the formulary listing criteria
levels. Last, we constructed a composite league table to rank the set of treatments
by priority order of reimbursement. A budget impact analysis was also conducted
to appraise the economic implications of the new composite drugs league table.
RESULTS: Policymakers in Côte d’Ivoire consider targeting cost-effectiveness and
severity of diseases as the most significant criteria for priority reimbursement of
drugs. This translates into a general preference for antimalarial, treatments for
asthma and antibiotics for urinary infection. Moreover, the results of the BIA sug-
gest that the new priority list of reimbursable drugs will be affordable when the real
economic impact of drugs per patient is under 66 US dollars. Over this threshold,
the MUGEFCI will have to select the reimbursable drugs according to their rank in
the priority list along with their respective budget impact per patient (cost per
patient). CONCLUSIONS: It is feasible to use MCDA to establish a formulary for
low-income countries. The application of this method is a step forward to trans-
parency in policymaking.
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OBJECTIVES: Robust and explicit methods to conduct systematic reviews of eco-
nomic evaluations are required to guarantee quality of reviews and their findings.
This is especially needed when assessing high resource-consuming topics such as
those related to the introduction of new imaging technologies. Our aim is to anal-
yse the methods for systematic reviews of economic evaluations of health
technologies. METHODS: We carried out a systematic review of methods for sys-
tematic reviews of economic evaluations by reading relevant parts of HTA meth-
odological manuals (“manuals”) and HTA reports from UK (“reports”) in English and
Italian at September 2010. RESULTS: We identified 27 manuals and 53 potential
reports. Among them, 6 and 40 contained relevant information respectively. None
of the 6 manuals described the criteria used for the identification or formulation of
the methods, or gave guidance on which method to follow. Among the 40 reports
included, 38/40 (95%) reports described search strategy and data bases used to
identify studies and inclusion criteria were presented in 21/40 (53%) reports. The
reports did not use a study quality assessment instrument were 9/40 (22.5%) while
20 different instruments were identified in the remaining reports. No report carried
out a quantitative synthesis of the data from the systematic review and 9/40 re-
ports (22.5%) clearly stated this. The reports that appear to include the data selec-
tively in their economic evaluation were 13/40 (32.5%). CONCLUSIONS: The ab-
sence of clear methodological guidance in manuals is reflected in the reports.
These show unclear rationale, methods and use of data from systematic reviews of
economic evaluations.
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OBJECTIVES: Many excellent health care databases are available in The Nether-
lands for (pharmaco-)epidemiologic research. However, in isolation these data re-
main scattered and have limitations with regard to sample sizes and/or detail of
the registered information.The objective of Mondriaan is to optimize access to en
linkage of routine health care databases in the The Netherlands for (pharmaco-
)epidemiologic research.METHODS:We have built an ICT infrastructure for collec-
tion and linkage of healthcare/research data in The Netherlands. To protect pri-
vacy, pseudonimisation and linkage is performed by a trusted third party (TTP). A
data catalogue on subject level has been developed to allow queries within the
integrated databases to support designing (pharmaco-) epidemiologic studies (incl.
sample size calculations, assessment of completeness of data). RESULTS: We are
able to routinely link all pharmacy records from the National Foundation of Phar-
maceutical Statistics (SFK) (n14,000,000) on a patient base to several routine
health care databases such as the Almere Health Care database (n200,000), the
Julius GP Network (n200,000), and the AGIS claims database (n1,200,000). Cur-
rently we are integrating several other databases in the The Netherlands.
CONCLUSIONS: The project will deliver a large-scale, high-quality data platform
for innovative (pharmaco-)epidemiologic research.
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OBJECTIVES: Many of the former socialist countries of Central and Eastern Europe
(CCEE) joined to the European Union in 2004. The aim of this study is to analyse to
outcome of ISPOR European and international congresses between 2005-2009 with
a special respect to the activity of CCEE. METHODS: We analysed the abstracts
presented at the ISPOR European or International cogresses and published in the
Value in Health journal between 2005-2009. We performed a database analysis of
value in Health journal on the Web of Science (Thomson Reuters) electronic data-
base of scientific publications. Three indicators were selected: author’s country,
institution (university) and name. RESULTS: The top-10 most active countries were
(abstract/1 million population): Switzerland (48.3), Wales (31.0), Sweden (26.2),
Denmark (25.3), Belgium (25.0), The Netherlands (23.0), England (19.3), Canada
(18.3), Scotland (16.0) and Hungary (14.7). Furthermore Slovakia (8.2) was ranked
16th, Czech Republic (5.0) 24th, Poland (4.1) 26th and Serbia (3.3) 29th. The top-10
most active universities were (number of abstracts): Univ So Calif (140), Univ To-
ronto (107), Univ Washington (100), Ohio State Univ (98), Erasmus Univ & MC (94),
Univ Maryland (93), Univ Pécs Hungary (93), Univ York (92), Harvard Univ (89) and
McMaster Univ (76). Three more CCEE university were ranked: Med Univ Warsaw
from Poland (38), Corvinus Univ Budapest from Hungary (30) and Comenius Univ
from Slovakia (27). The most active 10 authors were (number of abstracts): Boncz, I
(Hungary, 96), Taieb, C (France, 83), Balkrishnan, R (USA, Ohio, 77), Sebestyén, A
(Hungary, 71), Valentine, WJ (Switzerland, 65), Mantovani, LG (Italy, 60), Caro, JJ
(USA, MA, 57), Annemans, L (Belgium, 54), Kriszbahcer, I (Hungary, 52), Rejas, J
(Spain, 50). CONCLUSIONS: Former socialist countries of Central and Eastern Eu-
rope (CCEE) showed a significant activity at ISPOR European and International con-
gresses.
Research On Methods – Modeling Methods
PRM16
COVARIANCE STRUCTURES FOR MODELING LONGITUDINAL DATA
Purdy C
AHRM Incorporated, Buffalo, NY, USA
OBJECTIVES: The objective of this analysis is to compare several covariance struc-
tures which are used in the modeling of longitudinal data. METHODS: A PUBMED
search reveals is a steady increase in prospective observational studies over the
past five years. Repeated measures models are frequently used to analyze longitu-
dinal data. For the purpose of these comparisons, a series of longitudinal datasets
are simulated. In order to facilitate comparisons with applications to longitudinal
datasets involving utilities; the dependent variable in the simulation datasets is a
continuous variable restricted to the support interval [0, 1]. The predictor variables
include a set of categorical and continuous variables, including a time varying
covariate. Datasets with four different types of time dependence were compared
(no time trend, log time trend, linear trend, exponential trend). Models with the
following covariance structures were evaluated: compound symmetry, unstruc-
tured, autoregressive, heterogeneous autoregressive, variance components and
toeplitz. Model comparisons were based upon Akaike information criteria (AIC)
and the Bayesian information criteria (BIC). RESULTS: The preferred covariance
structures for the dataset without a time trend were heterogeneous autoregressive
(AIC) and unstructured (BIC). The preferred covariance structure for the log trend
dataset was unstructured (AIC and BIC). The preferred covariance structures for the
linear trend dataset were variance components (AIC) and heterogeneous autore-
gressive (BIC). The preferred covariance structure for the exponential trend dataset
was variance components (AIC and BIC). CONCLUSIONS: The unstructured cova-
riance matrix is often the default choice for the covariance matrix for longitudinal
models. This model has the least number of assumptions and allows for the mod-
eling of each patient individually. However, the unstructured covariance structure
requires the most degrees of freedom and in some cases the estimated covariance
matrix does not converge. In these cases, covariance structures such as variance
components and heterogeneous autoregressive may present attractive options.
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